Compound class:
Synthetic organic
Comment: Compound 23 is a selective cathepsin K inhibitor [2]. Cathepsin K (a collagenase) is upregulated in osteoclasts, chondrocytes and synoviocytes in osteoarthritic (OA) diseases, so inhibiting this cysteine protease would be expected to reduce/delay cartilage/subchondral bone destruction in OA joints [1]. Compound 23 is active in vitro and target engagement has been demonstrated in vivo.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Compound 23 is ≥1460-fold selectivefor cathepsin K compared to all other cathepsins tested [2]. |
Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|